Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MYOS

MYOS RENS Technology (MYOS)

MYOS RENS Technology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MYOS
FechaHoraFuenteTítuloSímboloCompañía
29/06/202316:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MYOSMYOS RENS Technology Inc
29/06/202316:23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:MYOSMYOS RENS Technology Inc
29/06/202316:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYOSMYOS RENS Technology Inc
21/06/202315:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MYOSMYOS RENS Technology Inc
20/06/202317:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MYOSMYOS RENS Technology Inc
19/05/202315:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MYOSMYOS RENS Technology Inc
18/05/202315:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYOSMYOS RENS Technology Inc
16/05/202305:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:MYOSMYOS RENS Technology Inc
01/05/202315:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MYOSMYOS RENS Technology Inc
14/04/202315:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MYOSMYOS RENS Technology Inc
14/02/202313:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MYOSMYOS RENS Technology Inc
21/10/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MYOSMYOS RENS Technology Inc
26/08/202215:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MYOSMYOS RENS Technology Inc
26/08/202215:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MYOSMYOS RENS Technology Inc
21/04/202215:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MYOSMYOS RENS Technology Inc
19/04/202214:53Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MYOSMYOS RENS Technology Inc
14/02/202216:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MYOSMYOS RENS Technology Inc
19/01/202216:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MYOSMYOS RENS Technology Inc
13/05/202105:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:MYOSMYOS RENS Technology Inc
19/04/202116:11Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:MYOSMYOS RENS Technology Inc
03/12/202011:22Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:MYOSMYOS RENS Technology Inc
30/11/202015:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MYOSMYOS RENS Technology Inc
17/11/202007:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MYOSMYOS RENS Technology Inc
17/11/202007:00PR Newswire (US)MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common...NASDAQ:MYOSMYOS RENS Technology Inc
12/11/202015:30PR Newswire (US)MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the MergerNASDAQ:MYOSMYOS RENS Technology Inc
06/11/202009:00PR Newswire (US)MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020NASDAQ:MYOSMYOS RENS Technology Inc
09/10/202016:30Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MYOSMYOS RENS Technology Inc
09/09/202007:00PR Newswire (US)MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health ImportanceNASDAQ:MYOSMYOS RENS Technology Inc
03/09/202005:02Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MYOSMYOS RENS Technology Inc
05/08/202007:00PR Newswire (US)MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 202...NASDAQ:MYOSMYOS RENS Technology Inc
 Showing the most relevant articles for your search:NASDAQ:MYOS

Su Consulta Reciente

Delayed Upgrade Clock